Associations of complement factor B and complement component 2 genotypes with subtypes of polypoidal choroidal
Koji Tanaka, Tomohiro Nakayama1, Ryusaburo Mori
1Department of Pathology and Microbiology, Nihon University School of Medicine, Tokyo, Japan. nakayama.tomohiro@nihon-u.ac.jp.
Complement factor genes C2 and CFB are associated with polypoidal choroidal vasculopathy (PCV) subtypes. Specific gene variants show a protective association with polypoidal CNV, differentiating it from typical PCV.
Area of Science:
- Ophthalmology
- Genetics
- Immunology
Background:
- Polypoidal choroidal vasculopathy (PCV) is a subtype of age-related macular degeneration.
- Previous research categorized PCV into polypoidal choroidal neovascularization (CNV) and typical PCV.
- The role of complement genes in PCV subtypes requires further investigation.
Purpose of the Study:
- To investigate the association between complement component 2 (C2) and complement factor B (CFB) genotypes and PCV subtypes.
- To determine if specific C2 and CFB variants differentiate polypoidal CNV from typical PCV.
Main Methods:
- Genotyping of single nucleotide polymorphisms (SNPs) in C2 (rs547154) and CFB (rs541862, rs2072633, rs4151667).
- Case-control studies were conducted on 677 patients with typical age-related macular degeneration (tAMD), PCV, and retinal angiomatous proliferation (RAP), and 282 PCV patients were subtyped.
- Logistic regression analysis was used to adjust for confounding factors.
Main Results:
- SNPs rs547154 and rs2072633 were associated with allele distributions in the overall PCV group.
- Specific C2 and CFB SNPs (rs547154, rs541862, rs2072633) showed significant differences in polypoidal CNV cases compared to controls, indicating a protective effect.
- The A/A genotype of rs2072633 was more common in polypoidal CNV than typical PCV.
Conclusions:
- PCV can be genetically distinguished into polypoidal CNV and typical PCV.
- C2 and CFB gene variants are significantly associated with polypoidal CNV.
- Typical PCV did not show association with the studied C2 and CFB gene variants.
Related Concept Videos
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
Genetic Lingo
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Pedigree Analysis
Pharmacogenomics: Identification of New Drug Targets


